Oyster Point Pharma, Inc. 3 SEC Filings

Filed On	Filing
03 Aug 2021	Form 3: Santel Donald J, Director No securities owned
05 Apr 2021	Form 3: Eliades George Christopher, Director No securities owned
13 Oct 2020	Form 3: Atieh Michael G, Director No securities owned
05 Nov 2019	Form 3: Kerins Patrick J, 10% owner Holds 5,925,287 shares of Common Stock, par value $0.001 per share
31 Oct 2019	Form 3: Barris Peter J, 10% owner Holds 322,458 shares of Common Stock, par value $0.001 per share
30 Oct 2019	Form 3: New Enterprise Associates 14, L.p., 10% owner and 7 others Holds 322,458 shares of Common Stock, par value $0.001 per share
30 Oct 2019	Form 3: Falcon Vision Llc, 10% owner and 3 others
30 Oct 2019	Form 3: Kkr Fund Holdings L.p., 10% owner and 6 others
30 Oct 2019	Form 3: Vida Ventures, Llc, 10% owner
30 Oct 2019	Form 3: InvOpps Gp IV, L.l.c., Director and 3 others
30 Oct 2019	Form 3: Kleiner Perkins Caufield & Byers XIV, Llc, 10% owner and 2 others Holds 322,458 shares of Common Stock, par value $0.001 per share
30 Oct 2019	Form 3: Versant Venture Capital VI, L.p., 10% owner and 8 others Holds 2,018 shares of Common Stock, par value $0.001 per share
30 Oct 2019	Form 3: Oyster Point Pharma I, Llc, 10% owner
30 Oct 2019	Form 3: Behbahani Ali, Director No securities owned
30 Oct 2019	Form 3: Clare Ozawa, Director
30 Oct 2019	Form 3: Weisner Aimee S, Director No securities owned
30 Oct 2019	Form 3: Tsai Benjamin, Director No securities owned
30 Oct 2019	Form 3: Link William J Phd, Director Holds 2,018 shares of Common Stock, par value $0.001 per share
30 Oct 2019	Form 3: Murray Mark Anthony, Director Holds 1,930 shares of Common Stock, par value $0.001 per share
30 Oct 2019	Form 3: Ackermann Michael, Director Holds 137,357 shares of Common Stock, par value $0.001 per share

Comments